Magnesium Sulfate and Postoperative Hypercoagulability in Laparoscopic Gynecological Surgeries
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Magnesium Sulfate, Thromboelastometry
In brief
This will be a prospective randomized, double-blind study, aiming at investigating the effects of magnesium sulfate on postoperative hypercoagulability in patients undergoing laparoscopic gynecological surgeries under general anesthesia
Key facts
- Study ID
- NCT06717490
- Run by
- Marianna Mavromati
- People needed
- 60
- Starts
- 2024-12-01
- Expected to finish
- 2025-11-01
- Last updated by the study team
- 2024-12-05
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- ASA I and II patients
- Laparoscopic gynecological surgeries
- age >18 years
- Patients receiving prophylactic anticoagulant therapy 12 hours before surgery based on the Caprini score
- Patients receiving prophylactic anticoagulant therapy 12 hours postoperatively based on the Caprini score.
You may not qualify if…
- ASA ≥ III
- age <18 years
- BMI >40 kg/m²
- Pregnancy
- Known hematologic disorders
- Liver/kidney/cardiovascular disease
- Severe anemia (6,5- 7,9 g/dl)
- Inability or refusal to provide informed consent
Where it is running
- Aretaieion University Hospital — Athens, Attica, Greece (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.